Skip to main content
Premium Trial:

Request an Annual Quote

Surromed, PPD Pen Proteomics Partnership

NEW YORK, Sept. 30 - Surromed today said it will use its mass-spectrometry platform to analyze tumor samples provided by PPD Discovery, the drug-discovery arm of PPD.

 

The research will be performed at Surromed's Biomarker Discover Lab in Menlo Park, Calif.

 

No other details were given.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.